EKF Diagnostics (LON:EKF) Stock Passes Above 200-Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 25.49 and traded as high as GBX 27. EKF Diagnostics shares last traded at GBX 27, with a volume of 458,312 shares.

Analyst Ratings Changes

Separately, Stifel Nicolaus reissued a “buy” rating and set a GBX 35 price target on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of GBX 35.

EKF Diagnostics Stock Performance

The firm’s 50 day moving average price is GBX 26.05 and its two-hundred day moving average price is GBX 25.49. The firm has a market cap of £116.24 million, a PE ratio of 57.45 and a beta of 0.52. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.